Phreesia, Inc. (NYSE:PHR – Get Free Report) CFO Balaji Gandhi sold 3,195 shares of Phreesia stock in a transaction on Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $85,018.95. Following the completion of the transaction, the chief financial officer now directly owns 148,509 shares in the company, valued at approximately $3,951,824.49. The trade was a 2.11 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Balaji Gandhi also recently made the following trade(s):
- On Tuesday, October 15th, Balaji Gandhi sold 864 shares of Phreesia stock. The shares were sold at an average price of $21.03, for a total value of $18,169.92.
Phreesia Stock Performance
Shares of Phreesia stock traded up $1.44 during trading hours on Wednesday, reaching $28.42. 668,317 shares of the stock traded hands, compared to its average volume of 410,783. Phreesia, Inc. has a one year low of $17.07 and a one year high of $29.16. The firm has a market capitalization of $1.65 billion, a price-to-earnings ratio of -19.33 and a beta of 0.94. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The company has a 50 day moving average price of $22.30 and a 200 day moving average price of $22.49.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on PHR shares. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their price target for the stock from $24.00 to $32.00 in a research note on Wednesday. Needham & Company LLC restated a “buy” rating and set a $29.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. KeyCorp increased their price objective on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Robert W. Baird dropped their target price on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. Eleven investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $30.64.
View Our Latest Analysis on PHR
Institutional Investors Weigh In On Phreesia
Institutional investors have recently added to or reduced their stakes in the stock. Champlain Investment Partners LLC boosted its holdings in shares of Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after purchasing an additional 97,847 shares during the last quarter. Franklin Resources Inc. lifted its stake in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after purchasing an additional 42,973 shares during the last quarter. State Street Corp grew its position in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after acquiring an additional 88,517 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Phreesia by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after purchasing an additional 55,934 shares during the period. Finally, TimesSquare Capital Management LLC lifted its holdings in Phreesia by 2.3% during the 3rd quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock valued at $19,791,000 after buying an additional 19,395 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.
About Phreesia
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Read More
- Five stocks we like better than Phreesia
- Technology Stocks Explained: Here’s What to Know About Tech
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Stock Average Calculator
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What is Put Option Volume?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.